Electrophysiological effects of vasoactive intestinal peptide in rabbit atrium: A modulation of acetylcholine activity

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 1, 1997, Pages 37-44

  Halimi, Franck ^a   Piot, Olivier ^a   Guize, Louis ^a   Le Heuzey, Jean Yves ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Acetycholine; Cellular electrophysiology; Refractory periods; Transmembrane action potential; Vasoactive Intestinal Peptide

Indexed keywords

ACETYLCHOLINE; CALCIUM ION; VASOACTIVE INTESTINAL POLYPEPTIDE; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART ATRIUM ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART RIGHT ATRIUM; MEMBRANE POTENTIAL; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPOLARIZATION;

EID: 0030892776     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0249     Document Type: Article

References (34)

1. BONKE FIM, ALLESSIE MA, KIRCHOF CJHJ, ROOS AGJM, 1985. Investigation of the conduction properties of the sinus node. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology and Arrhythmias. Orlando, Grune and Stratton, 73-79.
2. BRUM JM, BOVE AA, SUFAN Q, REILLY W, GO VW, 1986. Action and localization of vasoactive intestinal peptide in the coronary circulation: Evidence for nonadrenergic, noncholinergic coronary regulation. J Am Coll Cardiol 7: 406-413.
3. BUSCAIL L, CAUVIN A, GOURLET P, GOSSEN D, DE NEEF P, RATHE J, ROBBERECHT P, VANDERMEERS-PIRET MC, VANDERMEERS A, CHRISTOPHE J, 1990. Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucine (1-27) and secretin from the small intestine of guinea pig. Biochem Biophys Acta 1038: 355-359.
4. CHANG F, YU H, COHEN IS, 1994. Actions of vasoactive intestinal peptide and neuropeptide Y on the pacemaker current in canine Purkinje fibers. Circ Res 74:157-162.
5. CHATELAIN P, ROBBERECHT P, WAELBROEK M, DE NEEF P, CAMUS JC, NGUYEN HUU, ROBA J, CHRISTOPHE J, 1983. Topographical distribution of the secretin and VIP stimulated adenylate cyclase system in the heart of five animal species. Pflügers Arch 397: 100-105.
6. CHRISTOPHE J, WAELBROECK M, CHATELAIN P, ROBERECHT P, 1984. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Peptides 5: 341.
7. DELLA NG, PAPKA RE, FURNESS JB, COSTA M, 1983. Vasoactive intestinal peptide-like immunoreactivity in nerves associated with the cardiovascular system of guinea-pigs. Neuroscience 9: 605-619.
8. FLECKENSTEIN A, 1983. Selective suppression of the transsarcolemnial inward calcium current by calcium antagonists. In: Fleckenstein A, ed, Calcium Antagonism in Heart and Smooth Muscle. New York, Wiley-Interscience. 51-56.
9. FRANCO-CERECEDA A, BENGTSSON L, LUNDBERG JM, 1987. Inotropic effects of calcitonin gene-related peptide, vasoactive intestinal polypeptide and somatostatin on the human right atrium in vitro. Eur J Pharmacol 134: 69-76.
10. GILES WR, IMAIZUMI Y, 1988. Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol 405: 123-145.
11. 2+ antagonists and agonists in rabbit cardiac myocytes. Am J Physiol 260: 1737-1742.
12. GURANTZ D, HAROOTUNIAN AT, TSIEN RY, DIONNE VE, MARGIOTTA JF, 1994. VIP modulates neuronal nicotinic acetylcholine receptor function by a cyclic AMP-dependent mechanism. J Neurosci 14: 3540-3547.
13. HENNING RJ, 1992. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate. J Auton Nerv Syst 40: 121-129.
14. KARASAWA Y, FURUKAWA Y, REN LM, TAKEI M, MURAKAMI M, NARITA-MCHIBA S, 1990. Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. Eur J Pharmacol 187: 9-17.
15. KRALIOS AC, ANDERSON FL, KRALIOS FA, 1990. Myocardial electrophysiological effects of vasoactive intestinal peptide in dogs. Am J Physiol 259: 1559-1565.
16. LE HEUZEY JY, BOUTJDIR M, GAGEY S, LAVERGNE T, GUIZE L, 1989. Cellular aspects of atrial vulnerability. In: Attuel P, Coumel P, Janse MJ, eds, The Atrium in Health and Disease. Mount Kisco, Futura Publishing Co.
17. LEVY MIN, WARNER MR, 1990. Autonomic interactions in cardiac control: role of neuropeptides. In: Zipes D, Jalife J, eds, Cardiac Electrophysiology. Philadelphia, W. B. Saunders Co.
18. LUNDBERG J, 1981. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands: morphological, biochemical and functional studies. Acta Physiol Scand 496: 1-57.
19. MALHOTRA RK, WAKADE TD, WAKADE AR, 1989. Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol triphosphate, protein kinase C, and calcium in rat adrenal medulla. J Neurosci 9: 4150-4157.
20. PAES DE CARVALHO A, DE MELLO W, HOFFMANN BF, 1959. Electrophysiological evidence for specialized fiber types in rabbit atrium. Am J Physiol 196: 483.
21. PICKOFF AS, WANG SN, STOLFI A, RAMAGE D, ROSS-ASCUITTO NT, KYDON DW, ASCUITTO RJ, 1994. Vasoactive intestinal peptide: electrophysiologic activity in the newborn heart. Pediatr Res 35: 244-249.
22. RECHARDT L, AALTO SETALA K, PURJERANTA M, PELTO-HUIKKO M, KYÖSOLA K, 1986. Peptidergic innervation of human atrial myocardium: An electron microscopical and immunocytochemical study. J Auton Nerv Syst 17: 21-32.
23. REINECKE M, FORSSMANN WG, 1984. Regulatory peptides (SP, NT, VIP, PHI, ENK) of autonomic nerves in the guinea pig heart. Clin Exp Hypertens 6: 1867.
24. RIGEL DF, 1988. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP and NT. Am J Physiol 255: 311-317.
25. RIGEL DF, LATHROP DA, 1988. Vasoactive Intestinal Peptide facilities atrio-ventricular nodal conduction and shortens atrial refractory periods in conscious dogs (Abstract). Circulation 78: 11-536.
26. RIGEL DF, GRUPP IL, BALASUBRAMANIAM A, GRUPP G, 1989. Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles. Am J Physiol 257: 1082-1087.
27. RIGEL DF, LATHROP DA, 1991. Vasoactive intestinal polypeptide enhances automaticity of supraventricular pacemakers in anesthetized dogs. Am J Physiol 261: 463-468.
28. SAID SI, 1983. Vasoactive peptides. State of the art review. Hypertension 5: 17-26.
29. SAID SI, MUTT V, 1969. Polypeptide with broad biological activity: isolation from small intestine. Science: 1217-1218.
30. SAID SI, MUTT V, 19 70. Potent peripheral and splanchnic vasodilatator peptide from normal gut. Nature 225: 863-864.
31. + channels in arterial smooth muscle. Science 245: 177-180.
32. TATSUNO I, YADA T, VIGH S, HIDAKA H, ARIMURA A, 1992. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cystolic free calcium concentration in cultured rat hippocampal neurons. Endocrinology 131: 73-81.
33. WEIHE E, REINECKE M, 1981. Peptidergic innervation of the mammalian sinus nodes: Vasoactive intestinal polypeptide, neurotensin, substance P. Neurosci Lett 26: 283-288.
34. WEIHE E, REINECKE M, FORSSMANN WG, 1984. Distribution of vasoactive intestinal popypeptide-like immunoreactivity in the mammalian heart. Cell Tissue Res 236: 527-540.